Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 10;183(6):1650-1664.e15.
doi: 10.1016/j.cell.2020.10.025. Epub 2020 Oct 29.

Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos

Affiliations
Free article

Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos

Michael V Zuccaro et al. Cell. .
Free article

Abstract

Correction of disease-causing mutations in human embryos holds the potential to reduce the burden of inherited genetic disorders and improve fertility treatments for couples with disease-causing mutations in lieu of embryo selection. Here, we evaluate repair outcomes of a Cas9-induced double-strand break (DSB) introduced on the paternal chromosome at the EYS locus, which carries a frameshift mutation causing blindness. We show that the most common repair outcome is microhomology-mediated end joining, which occurs during the first cell cycle in the zygote, leading to embryos with non-mosaic restoration of the reading frame. Notably, about half of the breaks remain unrepaired, resulting in an undetectable paternal allele and, after mitosis, loss of one or both chromosomal arms. Correspondingly, Cas9 off-target cleavage results in chromosomal losses and hemizygous indels because of cleavage of both alleles. These results demonstrate the ability to manipulate chromosome content and reveal significant challenges for mutation correction in human embryos.

Keywords: Cas9; chromosome loss; double strand break repair; embryonic stem cells; germ-line gene editing; homologous recombination; human embryo; interhomolog recombination; microhomology mediated end joining; mitosis.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests J.X., R.Z., B.R., D.M., and N.T. are employees or shareholders of Genomic Prediction. S.H.T. is a consultant for SPARK Therapeutics and has grants from Abenoa Therapeutics. Dieter Egli is a member of the Cell Advisory Board.

Comment in

Publication types

MeSH terms

LinkOut - more resources